|
KAT2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.20909999790086E-08 |
| Normal-vs-Stage3 |
1.06292752377612E-12 |
| Normal-vs-Stage4 |
1.42660000035377E-07 |
| Stage1-vs-Stage2 |
5.127000E-01 |
| Stage1-vs-Stage3 |
5.868200E-01 |
| Stage1-vs-Stage4 |
5.423800E-01 |
| Stage2-vs-Stage3 |
3.223000E-01 |
| Stage2-vs-Stage4 |
3.126800E-01 |
| Stage3-vs-Stage4 |
6.382800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.4863998920589E-11 |
| Normal-vs-Asian |
4.987000E-04 |
| Caucasian-vs-AfricanAmerican |
4.788400E-02 |
| Caucasian-vs-Asian |
4.593400E-01 |
| AfricanAmerican-vs-Asian |
9.927400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.41531231179215E-12 |
| Normal-vs-Female |
2.77309997187558E-09 |
| Male-vs-Female |
4.562200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.06249470227726E-11 |
| Normal-vs-Extreme_Weight |
1.86350934683333E-12 |
| Normal-vs-Obese |
9.08717545655691E-13 |
| Normal-vs-Extreme_Obese |
2.10720000004549E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.265800E-01 |
| Normal_Weight-vs-Obese |
5.419000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.962200E-01 |
| Extreme_Weight-vs-Obese |
3.888100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.646600E-01 |
| Obese-vs-Extreme_Obese |
4.108200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.77299999962288E-07 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.14000000053893E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.207200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.964570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.145400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.448000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.684800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.328800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
2.33146835171283E-15 |
| Normal-VS-KIRP CIMP |
1.769350E-04 |
| Normal-VS-Unclassified PRCC |
1.03739999923746E-08 |
| Type1 PRCC-VS-Type2 PRCC |
4.402800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.207600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.060780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.636560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.637400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.882400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86357612569554E-14 |
| Normal-vs-N1 |
1.17660325926749E-11 |
| Normal-vs-N2 |
3.158900E-04 |
| N0-vs-N1 |
9.061000E-01 |
| N0-vs-N2 |
4.857200E-01 |
| N1-vs-N2 |
4.066200E-01 |
|
|
